triamcinolone acetonide 0.1% dental paste (Kenalog Orabase, Oralone)

  • Medical Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Charles Patrick Davis, MD, PhD
    Charles Patrick Davis, MD, PhD

    Charles Patrick Davis, MD, PhD

    Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.

Shocking Diseases of the Mouth

Depending on severity of symptoms, two or three applications per day may be required, preferably after meals. The paste should be applied at bedtime to allow contact with the lesion throughout the night. If symptoms do not improve in seven days, patients should seek further medical advice.

To prevent unwanted side effects, corticosteroids should be used for the shortest duration possible. Therapy should be discontinued as soon as control of symptoms is achieved.

Triamcinolone acetonide dental paste should not be used in the presence of fungal, viral, or bacterial infections of the mouth or throat.

DRUG INTERACTIONS: Since triamcinolone acetonide dental paste is used topically and for short durations, clinically significant blood absorption is not thought to occur. As a result, the risk for drug interactions with triamcinolone acetonide dental paste and other medications is relatively low.

PREGNANCY: Triamcinolone acetonide has been shown to cause birth defects in several animal species. As there are no adequate and well-controlled studies in pregnant women, the risk of birth defects in humans is not known. Triamcinolone acetonide dental paste should only be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Triamcinolone acetonide dental paste is classified as FDA pregnancy risk category C (Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks).

NURSING MOTHERS: It is not known if oral application of triamcinolone acetonide results in detectable secretions into breast milk. Therefore, to avoid unwanted adverse effects in the nursing infant, triamcinolone dental paste should be used cautiously in nursing mothers.

REFERENCE: FDA Prescribing Information.

Medically Reviewed by a Doctor on 6/11/2015

Quick GuideCosmetic Dentistry Before and After Photos

Cosmetic Dentistry Before and After Photos
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Newsletters

Get the latest health and medical information delivered direct to your inbox!

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors